Fixed 3.7-GBq 131I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History

被引：5

作者：

Jentzen, Walter ^{[1
]}

Nahum, Alan E. ^{[1
]}

Bockisch, Andreas ^{[1
]}

Binse, Ina ^{[1
]}

Tulchinsky, Mark ^{[1
]}

机构：

[1] Klin Nukl Med, Hufelandstr 55, D-45122 Essen, Germany

来源：

JOURNAL OF NUCLEAR MEDICINE | 2017年 / 58卷 / 09期

关键词：

RADIOIODINE THERAPY;

D O I：

10.2967/jnumed.117.192872

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：1530 / 1530

页数：1

共 37 条

[21] Dosimetry during adjuvant 131I therapy in patients with differentiated thyroid cancer-clinical implications [J].

Szumowski, Piotr ;

Abdelrazek, Saeid ;

Iwanicka, Dorota ;

Mojsak, Malgorzata ;

Sykala, Monika ;

Zukowski, Lukasz ;

Siewko, Katarzyna ;

Adamska, Agnieszka ;

Maliszewska, Katarzyna ;

Poplawska-Kita, Anna ;

Szelachowska, Malgorzata ;

Kretowski, Adam ;

Mysliwiec, Janusz .

SCIENTIFIC REPORTS, 2021, 11 (01)

[22] Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in 124I PET/CT-Based Dosimetry for 131I Therapy of Metastatic Differentiated Thyroid Cancer [J].

Plyku, Donika ;

Hobbs, Robert F. ;

Huang, Kevin ;

Atkins, Frank ;

Garcia, Carlos ;

Sgouros, George ;

Van Nostrand, Douglas .

JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (07) :1146-1154

[23] The prevalence of thyroglossal tract thyroid tissue on SPECT/CT following 131I ablation therapy after total thyroidectomy for thyroid cancer [J].

Barber, Thomas W. ;

Cherk, Martin H. ;

Topliss, Duncan J. ;

Serpell, Jonathan W. ;

Yap, Kenneth S. K. ;

Bailey, Michael ;

Kalff, Victor .

CLINICAL ENDOCRINOLOGY, 2014, 81 (02) :266-270

[24] Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I [J].

Pettinato, C. ;

Monari, F. ;

Nanni, C. ;

Allegri, V. ;

Marcatili, S. ;

Civollani, S. ;

Cima, S. ;

Spezi, E. ;

Mazzarotto, R. ;

Fanti, S. .

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 56 (06) :509-514

[25] Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients Dosimetry-based model for estimation [J].

Jentzen, W. ;

Moldovan, A. -S. ;

Ruhlmann, M. ;

Goerges, R. ;

Bockisch, A. ;

Rosenbaum-Krumme, S. .

NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2015, 54 (03) :137-143

[26] Selected Radiation Safety Aspects Including Transportation and Lodging After Outpatient 131I Therapy for Differentiated Thyroid Cancer [J].

Gomes-Lima, Cristiane J. ;

Wu, Di ;

Kharazi, Pejman H. ;

Khojekar, Gauri J. ;

Ringel, Matthew D. ;

Vetter, Richard J. ;

Bloom, Gary ;

Burman, Kenneth D. ;

Wartofsky, Leonard ;

Van Nostrand, Douglas .

THYROID, 2017, 27 (12) :1558-1565

[27] Red marrow and blood dosimetry in 131I treatment of metastatic thyroid carcinoma: pre-treatment versus in-therapy results [J].

Giostra, A. ;

Richetta, E. ;

Pasquino, M. ;

Miranti, A. ;

Cutaia, C. ;

Brusasco, G. ;

Pellerito, R. E. ;

Stasi, M. .

PHYSICS IN MEDICINE AND BIOLOGY, 2016, 61 (11) :4316-4326

[28] Pretherapeutic Dosimetry in Patients Affected by Metastatic Thyroid Cancer Using 124I PET/CT Sequential Scans for 131I Treatment Planning [J].

Pettinato, Cinzia ;

Spezi, Emiliano ;

Nanni, Cristina ;

Grassetto, Gaia ;

Monari, Fabio ;

Allegri, Vincenzo ;

Civollani, Simona ;

Cima, Simona ;

Zagni, Paolo ;

Mazzarotto, Renzo ;

Colletti, Patrick M. ;

Rubello, Domenico ;

Fanti, Stefano .

CLINICAL NUCLEAR MEDICINE, 2014, 39 (08) :E367-E374

[29] Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience [J].

Verburg, Frederik A. ;

Haenscheid, Heribert ;

Biko, Johannes ;

Hategan, Maria C. ;

Lassmann, Michael ;

Kreissl, Michael C. ;

Reiners, Christoph ;

Luster, Markus .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (05) :896-903

[30] Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer [J].

George Sgouros ;

Robert F. Hobbs ;

Francis B. Atkins ;

Douglas Van Nostrand ;

Paul W. Ladenson ;

Richard L. Wahl .

European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 :41-47

← 1 2 3 4 →